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Abstract 
BACKGROUND:  
The temporomandibular joint (TMJ) cartilage consists of condylar cartilage and disc 
and undergoes continuous remodeling throughout post-natal life.  To maintain the 
integrity of the TMJ cartilage, anti-angiogenic factors play an important role during 
the remodeling process.  In this study we investigated the expression of the 
anti-angiogenic factor, chondromodulin-1 (ChM-1), in TMJ cartilage and evaluate its 
potential role in TMJ remodeling.  
METHODS: 
Eight TMJ specimens were collected from six 4-month-old Japanese white rabbits.  
Safranin-O staining was performed to determine proteoglycan content. ChM-1 
expression in TMJ condylar cartilage and disc was determined by 
immunohistochemistry. Three human perforated disc tissue samples were collected 
for investigation of ChM-1 and vascular endothelial growth factor (VEGF) 
distribution in perforated TMJ disc.  
RESULTS: 
Safranin-O stained weakly in TMJ compared with tibial articular and epiphyseal 
cartilage.  In TMJ, ChM-1 was expressed in the proliferative and hypertrophic zones 
of condylar cartilage and chondrocyte-like cells in the disc.  No expression of 
ChM-1 was observed in osteoblasts and subchondral bone.  ChM-1 and VEGF were 
both similarly expressed in perorated disc tissues. 
CONCLUSIONS: 
ChM-1 may play a role in theis a putative regulationor ofin TMJ remodeling, byacting 
by preventinging blood vessel invasion of the cartilage,, therebyus maintaining 
condylar cartilage and disc integrity.  
Introduction  
 
Temporomandibular joint (TMJ) remodeling is physiologically a complicated 
procedure, which involves both chondrogenesis and osteogenesis (1, 2).  The TMJ, 
which includes the condylar cartilage and TMJ disc, is a unique structure and differs 
from other synovial joints in that it requires constant remodeling throughout life.  
TMJ condylar cartilage remodeling is related to mandibular growth and in adaption to 
occlusion movement, as well as load bearing during masticating and some 
pathological changes such as disc perforation (3, 4).  Angiogenesis is a crucial step 
in TMJ remodeling, as it regulates the transformation from cartilage to bone (5).  
Angiogenesis is accompanied by the expression of angiogenic factors such as vascular 
endothelial growth factor (VEGF), which involves the formation of new blood vessels 
from pre-existing vessels to form a capillary networks.  During long bone growth, 
VEGF is expressed in hypertrophic chondrocytes leading to the recruitment of 
endothelial cells into the cartilage with subsequent osteogenic induction (6).  VEGF 
expression has been reported in the hypertrophic zone of healthy TMJ condylar 
cartilage during remodeling (7).  This is paradoxical given that cartilage is an 
avascular tissue and angiogenesis in cartilage is detrimental to the maintenance of its  
integrity, a condition which is typically the forerunner of osteoarthritis (8).  The 
healthy TMJ disc is subject to remodeling, as is condylar cartilage (9).  Therefore, 
angiogenic and antiangiogenic factors need to be well regulated to maintain the TMJ 
and disc integrity.  However, the molecular mechanisms, underlying the maintenance 
of the structural integrity during TMJ remodeling, remains unclear.   
 ChM-1, a 25-kDa glycoprotein, is an anti-angiogenic factor and has been purified 
from articular cartilage.  ChM-1 has been found to be strongly expressed in 
immature cartilage and prevents blood vessels growing into the cartilage.  It has been 
suggested that ChM-1 is responsible for maintaining the cartilage integrity during 
osteogenesis (10).  TMJ cartilage is classified as a fibrocartilage and differs from 
other synovial joints cartilage by expressing type I rather than type II collagen (11).  
Previous studies have tended to focus on the angiogenic factors in TMJ remodeling 
(12), whereas little is known of the anti-angiogenic factors in TMJ.  In this study we 
investigated, by immunohistochemistry, the spatial distribution of ChM-1 in TMJ 
condylar cartilage and disc.  
 
Materials and Methods 
This study was carried out according to the guideline of the Animal Ethics Committee 
at School of Stomatology, Wuhan University.  A total of eight temporomandibular 
joints (five right sides, three left sides) were harvested from six healthy 4-month-old 
Japanese white rabbits; the animals weighing approximately 2kg each.  Four samples 
harvested from the tibia of adult female Lewis rats served as positive controls.  
Three perforated TMJ disc tissues were obtained from human volunteers undergoing 
TMJ disc surgery after informed consent was given.  Except for the human samples, 
all the other samples were removed and fixed in 4% paraformaldehyde for 48 hr, 
decalcified in a 10% ethylenediaminetetraacetic acid disodium (EDTA-2Na) solution 
for 4 weeks at 4℃, and then embedded in paraffin.  Serial sagittal sections (5µm) of 
the paraffin blocks were cut with a Leica RM2265 microtome (Leica, Wetzlar, 
Germany).  The sections were dewaxed in xylene and then hydrated in gradual 
decreased ethanol concentrations.  For Safranin-O staining, sections were first 
stained with Weigert’s haematoxylin (HT107 & HT109, Sigma-Aldrich, St. Louis, 
MO, USA) for 10 min, dedifferentiated with acid alcohol, then stained with fast green 
and Safranin-O for 5 min respectively.  The sections were washed and dehydrated in 
gradual increased ethanol and cleared in xylene, and finally mounted with Depex 
mounting medium (BDH Laboratory, Poole, UK). 
Immunohistochemistry was performed using a goat anti-human ChM-1 antibody, 
(sc-20310; Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA).  The sections 
were first incubated with proteinase K for 10 min, and then incubated with 3% H202 
for 20 min to inactivate endogenous peroxidase.  Non-specific binding was blocked 
with a donkey blocking serum (diluted 1:10 in PBS, sc-2044, Santa Cruz 
Biotechnology, Inc, Santa Cruz, CA, USA).  The sections were incubated with 
ChM-1 antibody (diluted 1:100) in a humidified chamber at 4°C overnight, after 
which they were washed thoroughly with PBS, incubated with biotin-conjugated 
donkey anti-goat IgG (diluted 1:100; sc-2042 ,Santa Cruz Biotechnology, Inc, Santa 
Cruz, CA, USA), in a humidified chamber for 30 min, at room temperature, and then 
rinsed thoroughly with PBS and incubated with streptavidin conjugated horseradish 
peroxidase (DAKO, Carpinteria, CA, USA).  Finally, the bound immunocomplex 
was visualized by immersing the sections in 3, 3’-diaminobenzidine (Sigma, St. Louis, 
MO, USA) for 2 min.  Negative controls were provided by replacing the primary 
antibody with diluted BSA.  Rabbit anti-human VEGF antibody 
(RB-220-P1,Thermo scientific, Fremont, CA, USA) was used to detect the expression 
of VEGF in human disc tissues and followed the same protocol as above, but 
excluding proteinase K incubation.  Sections were counterstained with Mayer’s 
haematoxylin (Sigma, St. Louis, MO, USA), and mounted with Depex mounting 
medium.  
Safranin-O staining, ChM-1 and VEGF immunoreactivity were independently 
evaluated by two experienced researchers and the intensity of staining was assessed 
and graded as either no expression, weak, moderate, or strong expression. 
 
Results 
Safranin-O staining 
In the tibia, positive Safranin-O staining extended throughout the full thickness of 
articular and epiphyseal cartilage (Fig.1a and b).  Staining was absent in the 
superficial zone of articular cartilage and subchondral bone (Fig.1a and b, table 1). 
 
In the TMJ, positive Safranin-O staining was weaker in condylar cartilage and disc, 
compared to staining found in the tibia samples (Fig.1c and d, table 1).  The matrix 
of disc stained very weakly (Fig.1c) and the only positive staining was associated with 
chondrocyte-like cells (Fig.1c).  Positive staining was noted in the proliferative and 
hypertrophic zone in condylar cartilage (Fig.1d), whereas no staining was found in 
fiber zone of condylar cartilage (Fig.1d, table 1). 
 
ChM-1 immunostaining. 
In the tibial articular cartilage the expression of ChM-1 was faint and found around 
the chondrocytes, with no obvious staining in cartilage matrix (Fig.2a).  ChM-1 was 
expressed in the resting, proliferating and hypertrophic zones of epiphyseal cartilage 
and found both in chondrocytes and cartilage matrix (Fig.2b).  There was no ChM-1 
immunoreaction in the subchondral bone. 
In the rabbit TMJ samples, ChM-1 expressed strongly in the cytoplasm of 
chondrocyte-like cells in anterior, intermediate and posterior bands and bilaminar 
zones throughout the disc, except for the superficial layer (Fig.2c, table 1).  ChM-1 
expression was predominantly located in the proliferative and hypertrophic zone of 
condylar cartilage and the immunoreactions was in the cytoplasms of ChM-1 positive 
cells (Fig.2d).  There was an absence of ChM-1 staining in the fiber zone and in the 
matrix of the disc (Fig.2c), subchondral bone of TMJ (Fig.3), and in the synovium. 
 
ChM-1 and VEGF expression in Human perforated disc samples 
 
In human perforated disc samples, ChM-1 expression was noted in most 
chondrocyte-like cells (Fig 4a).  A similar distribution of VEGF was also detected in 
all the patient’s samples collected from the perforated TMJ discs (Fig 4b).    
Discussion 
TMJ cartilage, which includes the condylar cartilage and disc, is a fibrocartilage 
which undergoes remodeling in response to external stimuli.  Previous studies have 
found that the amount of proteoglycan in TMJ cartilage is relatively lower than that 
found in other synovial joint cartilage (13).  In our study we found that the positive 
staining of safranin-O was weaker in TMJ condylar cartilage than in tibia articular 
and epiphyseal cartilage.  The safranin-O staining was restricted to the areas 
surrounding of chondrocyte-like cells in the disc, which is evidence of TMJ 
remodeling. 
TMJ cartilage is surrounded by an angiogenic microenvironment with the expression 
of VEGF in the hypertrophic zone of healthy TMJ condylar cartilage (7). An 
angiogenic microenvironment typically leads to blood vessel invasion and a loss of 
cartilage matrix (12, 14).  An earlier study has showed that angiogenesis is involved 
in cartilage matrix degeneration and osteophyte formation in OA (15).  It is therefore 
a reasonable hypothesis that antiangiogenic factors play an important regulatory role 
in maintaining healthy TMJ cartilage integrity.  ChM-1 is a specific anti-angiogenic 
factor isolated from cartilage (16), and is strongly expressed in growing articular 
cartilage, epiphyseal cartilage, and normal adult joints, playing a role in the 
maintenance of avascularity in articular cartilage (10, 17-19).  Its presence 
modulates the angiogenic effect of hypoxia (20) and inhibits DNA synthesis and 
proliferation of vascular endothelial cells, as well as in vitro tube morphogenesis (21). 
During the growth period, ChM-1 is expressed throughout articular and epiphyseal 
cartilage to modulate endochondral ossification, a process similar to the remodeling in 
TMJ.  ChM-1 expression decreases in mature articular cartilage, but is still expressed 
in epiphyseal cartilage after growth (10).  An in vitro study found that, in response to 
differentiation stimuli, ChM-1 mRNA expression in primary cultured chondrocytes 
was markedly down-regulated (22).  An absence of ChM-1 creates a 
microenvironment which favors blood vessel invasion into cartilage (23). However, 
the role of ChM-1 in TMJ cartilage is unclear and has not been subject to 
investigation.   
In this study, we provide evidence for the expression of ChM-1 in adult TMJ condylar 
cartilage.  ChM-1 was strongly expressed in TMJ condylar cartilage in the 
proliferative and hypertrophic zones, a front line to blood vessel invasion.  This 
expression profile was similar to ChM-1 expression in epiphyseal cartilage but 
different to the distribution in articular cartilage (10), which indicates that angiogenic 
properties between TMJ cartilage and articular cartilage are different.  VEGF has 
been identified in healthy condylar cartilage and here the presence of ChM-1 could 
act as a barrier which prevents blood vessel invasion into the cartilage.  The role of 
ChM-1 expression in the TMJ condyle may therefore be of a similar nature to that in 
immature articular cartilage and epiphyseal cartilage, suggesting that ChM-1 regulates 
TMJ remodeling, thus maintaining TMJ cartilage integrity.  
 
The TMJ disc undergoes a synchronized remodeling together with the TMJ articular 
cartilage remodeling (24).  The TMJ disc is an avascular tissue and our findings 
suggest that the existence of ChM-1 in the disc may prevent blood vessel invasion.  
In TMJ disorders, disc perforation is an important pathological symptom of the 
disease.  The perforated disc does not readily repair by natural wound healing, even 
though VEGF has been observed in disc chondrocyte-like cells located in disc 
perforation areas (25).  In this study, we found that VEGF was expressed in 
chondrocyte-like cells of perforated TMJ disc.  Interestingly, ChM-1 was also found 
to be distributed similarly in chondrocyte-like cells.  It is therefore possible that the 
existence of ChM-1 neutralizes the angiogenic effect of VEGF and prevents blood 
vessel invasion at the arthropathic site thereby retarding perforation healing.  The 
distribution of ChM-1 in fibrocartilage tissue has been reported in intervertebral disc 
(26) and in the remaining chondrocytes in the degenerative intervertebral disc (27). 
  
TMJ remodeling is a physiologically complicated process which involves both 
chondrogenesis and osteogenesis.  Interaction between angiogenic and 
anti-angiogenic factors regulates TMJ remodeling, maintaining the avascular property 
and integrity of TMJ cartilage so that the joint can function normally.  Our findings 
suggest that ChM-1 plays an important role in both condylar cartilage and TMJ disc 
by maintaining the avascular properties during TMJ remodeling and disc perforation.   
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Legends  
Figure 1: Representative images of Safranin O staining in cartilage. In tibia, Safranin 
O staining was intense ive in articular (a) and epiphyseal (b) cartilage. In TMJ, 
Safranin O staining was faint in disc (c) condylar cartilage (d) and limited to the 
surrounding of disc cells (c).  A: articular cartilage; C: condylar cartilage; D: TMJ 
disc; E: epiphyseal cartilage; Em: articular eminence; F: the fibrosis zone; H: the 
hypertrophic zone; P: the proliferative zone; R: the resting zone. Bar = 100µm 
 
Figure 2: Representative images of Iimmunostaining for ChM-1 in cartilage. In tibia, 
ChM-1 expression was faint in articular cartilage (a) but intense in epiphyseal 
cartilage (b). In TMJ, ChM-1 expression was limited to cells in the disc and absent in 
the disc matrix (c) ChM1 staining was intense in condylar cartilage (d). A: articular 
cartilage; C: condylar cartilage; D: TMJ disc; E: epiphyseal cartilage; F: the fibrosis 
zone; H: the hypertrophic zone; P: the proliferative zone; R: the resting zone. Bar = 
100µm 
 
Figure 3: There was an absence of ChM-1 staining in TMJ condylar subchondral 
bone. Arrow indicates subchondral bone.  Bar = 50µm 
 
Figure 4: ChM-1 (a) and VEGF (b) expression in chondrocyte-like cells in human 
TMJ perforated disc samples. Bar =50µm Arrows in figures a and b show positive 
cells in TMJ disc respectively. Bar =20 µm. 
 Table 1: Staining intensity of Safranin O and ChM-1 in tibia and TMJ cartilage 
 
